Skip to Content

Join the 'Tuberculosis - HIV Positive' group to help and get support from people like you.

Tuberculosis - HIV Positive News

Global Efforts to Combat TB Epidemic Falling Short

Posted 13 Oct 2016 by Drugs.com

THURSDAY, Oct. 13, 2016 – Countries around the world need to work harder to combat tuberculosis infections and deaths, a new World Health Organization report says. Nations across the globe have pledged to reduce tuberculosis (TB) infections by 80 percent and TB deaths by 90 percent by 2030, but they must work faster if they want to meet these goals, according to the WHO. "We face an uphill battle to reach the global targets for tuberculosis," WHO Director General Dr. Margaret Chan said in an organization news release. "There must be a massive scale-up of efforts, or countries will continue to run behind this deadly epidemic and these ambitious goals will be missed." Tuberculosis is a disease that mainly affects the lungs. The bacteria that cause TB are primarily spread from person to person through tiny droplets from coughs and sneezes. The global response to the TB epidemic did manage ... Read more

Related support groups: Tuberculosis, Rifampin, Tuberculosis - Latent, Ethambutol, Tuberculosis - Active, Pulmonary Tuberculosis, Tuberculosis - Prophylaxis, Diagnosis and Investigation, Pyrazinamide, Tuberculosis - Extrapulmonary, Rifamate, Isoniazid/Rifampin, Rifabutin, Tuberculosis - HIV Status Unknown, Tuberculous Meningitis, Myambutol, Rifater, Tuberculosis - Resistant, Mycobutin, Rifadin

Tuberculosis Decline in U.S. Has Stalled, CDC Reports

Posted 24 Mar 2016 by Drugs.com

THURSDAY, March 24, 2016 – Two decades of progress toward eliminating tuberculosis in the United States has stalled, with incidence of the lung disease holding steady from 2013 to 2015, a federal government report shows. "Resuming progress toward TB elimination in the United States will require intensification of efforts both in the U.S. and globally," said researchers from the U.S. Centers for Disease Control and Prevention's National Tuberculosis Surveillance System. If not treated, TB can be fatal. The bacterial infection is spread through the air, when someone infected coughs, sneezes or speaks. However, it is not easily transmitted – you must be in close contact with someone who has TB for a long period of time, according to the American Lung Association. Overall, TB incidence leveled off at about three new cases per 100,000 people each year between 2013 and 2015, according to ... Read more

Related support groups: Xifaxan, Tuberculosis, Rifampin, Rifaximin, Tuberculosis - Latent, Tuberculosis - Active, Pulmonary Tuberculosis, Tuberculosis - Prophylaxis, Tuberculosis - Extrapulmonary, Isoniazid/Rifampin, Rifamate, Rifabutin, Rifater, Mycobutin, Tuberculosis - Resistant, Rifadin, Tuberculosis - HIV Negative, Rifapentine, Tuberculosis - HIV Positive, Rimactane

Screen High-Risk Adults for Tuberculosis, Experts Say

Posted 8 Mar 2016 by Drugs.com

TUESDAY, March 8, 2016 – Adults at greater risk for latent tuberculosis infection should be screened for the condition, the U.S. Preventive Services Task Force recommends. "The task force recommends that primary care clinicians screen adults at increased risk for [latent TB] to help prevent the progression to active TB," panel member Dr. Francisco Garcia said in a task force news release. Garcia is director and chief medical officer of the Pima County Health Department in Tucson, Ariz. Tuberculosis, commonly known as TB, is an infection caused by bacteria. Anyone in close contact with someone with tuberculosis may be exposed to the bacteria. It spreads through the air when an infected person coughs or sneezes, according to the health panel. TB usually attack the lungs, but the bacteria can attack any part of the body such as the kidney, spine and brain. If it isn't treated properly, ... Read more

Related support groups: Tuberculosis, Tuberculosis - Latent, Tuberculosis - Active, Pulmonary Tuberculosis, Tuberculosis - Prophylaxis, Tuberculosis - Extrapulmonary, Tuberculosis - HIV Negative, Tuberculosis - Resistant, Tuberculosis - HIV Positive, Adrenal Tuberculosis

New TB Test May Help Simplify Diagnosis

Posted 20 Feb 2016 by Drugs.com

FRIDAY, Feb. 19, 2016 – A simple new blood test for tuberculosis may one day help improve diagnosis and treatment of the deadly disease in developing countries, researchers report. The inexpensive test identifies a gene expression "signature" that distinguishes people with active TB from those with either latent TB or other diseases, according to the research team from the Stanford University School of Medicine, in Palo Alto, Calif. The work is outlined in a paper published online Feb. 19 in The Lancet Respiratory Medicine journal. Each year, 9.6 million people worldwide are newly infected with TB, a bacterial infection that usually affects the lungs, and 1.5 million die from the difficult-to-diagnose disease, the researchers noted. "One-third of the world's population is currently infected with TB. Even if only 10 percent of them get active TB, that's still 3 percent of the world's ... Read more

Related support groups: Tuberculosis, Tuberculosis - Latent, Tuberculosis - Active, Pulmonary Tuberculosis, Tuberculosis - Prophylaxis, Diagnosis and Investigation, Tuberculosis - Extrapulmonary, Tuberculous Meningitis, Tuberculosis - Resistant, Tuberculosis - HIV Negative, Tuberculosis - HIV Status Unknown, Tuberculous Esophagitis, Adrenal Tuberculosis, Tuberculosis - HIV Positive, Tuberculosis - Urinary Tract, Ocular Tuberculosis, Tuberculous Pleurisy

Start HIV Drug Treatment Early in Patients With TB: Studies

Posted 19 Oct 2011 by Drugs.com

WEDNESDAY, Oct. 19 – Three new studies provide insight into the best time to begin AIDS drug treatments in HIV-positive patients who are also infected with tuberculosis, a double whammy common in Africa. Starting the drugs earlier, even by a few weeks, could make a big difference for patients who are very sick, the research suggests. The cost of earlier treatment isn't much higher, and the drugs pay big dividends, said Dr. Diane V. Havlir, lead author of one of the studies. Her study found that starting the drugs within two weeks of diagnosis rather than eight weeks reduced the death rate or progression to more severe HIV by almost 40 percent in the sickest patients. "This is fabulous news. It's amazing that starting it at two weeks versus eight weeks makes such a difference," said Havlir, professor of medicine at the University of California, San Francisco, and head of the AIDS ... Read more

Related support groups: HIV Infection, Tuberculosis, Tuberculosis - HIV Positive

In San Diego, Hispanics Now Dominate HIV/TB Cases

Posted 17 Feb 2010 by Drugs.com

WEDNESDAY, Feb. 17 – Hispanics account for 80 percent of the cases of tuberculosis/HIV co-infection in San Diego, which represents a significant change in the racial profile of the disease, a new study shows. "While the overall numbers are modest, our study shows that what used to be mostly a disease of white and black patients in San Diego is now largely a disease of Hispanics," Dr. Timothy Rodwell, an associated physician/fellow in the Division of Global Public Health at the University of California, San Diego, said in a university news release. This shift "indicates that the benefits of prevention and treatment of TB and HIV over the last decade have been uneven in the different ethnic/racial groups in this region," Rodwell added. He and his colleagues analyzed 5,172 TB cases recorded in San Diego County between 1993 and 2007 and found that 8.8 percent of those patients were also ... Read more

Related support groups: Tuberculosis - HIV Positive

Ask a Question

Further Information

Related Condition Support Groups

Tuberculosis

Related Drug Support Groups

rifabutin, Mycobutin